Insider Sell: Natera
9:32AM ET 10/06/2021 MT NewswiresSteven Leonard Chapman, Director, CEO AND PRESIDENT, on October 02, 2021, sold 21,157 shares in Natera (NTRA) for $2,288,781. Following the Form 4 filing...
Quotes Snapshot > NTRA
Natera Inc NTRA:NASDAQ
Last Price$114.93NASDAQ Previous Close - Last Trade as of 4:00PM ET 10/22/21
NASDAQ 15-minute delayed Bid/Ask Quotes
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$109.01 (125)
Ask (Size)$121.05 (25)
Day Low / HighN/A - N/A
Volume561.6 K
Read more news Recent News
Insider Sell: Natera
10:01AM ET 9/30/2021 MT NewswiresMichael Burkes Brophy, CHIEF FINANCIAL OFFICER, on September 27, 2021, sold 25,947 shares in Natera (NTRA) for $2,974,936. Following the Form 4 filing with...
Insider Sell: Natera
9:33AM ET 9/27/2021 MT NewswiresSteven Leonard Chapman, Director, CEO AND PRESIDENT, on September 22, 2021, sold 28,563 shares in Natera (NTRA) for $3,411,189. Following the Form 4 filing...
Insider Sell: Natera
8:05AM ET 9/13/2021 MT NewswiresSteven Leonard Chapman, Director, CEO AND PRESIDENT, on September 09, 2021, sold 90,968 shares in Natera (NTRA) for $10,890,042. Following the Form 4...
View all Commentary and Analysis
Healthcare Marches To The Top, Opportunities For Further Gains
8:00AM ET 9/07/2021 Seeking AlphaThe Exploitable Genomics Of Cancer: Earlier Cancer Detection Part II
7:56AM ET 9/03/2021 Seeking AlphaNatera, Inc. 2021 Q2 - Results - Earnings Call Presentation
2:02PM ET 8/09/2021 Seeking AlphaNatera, Inc. (NTRA) CEO Steve Chapman on Q2 2021 Results - Earnings Call Transcript
10:17AM ET 8/08/2021 Seeking AlphaCompany Profile
Business DescriptionNatera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA. View company web site for more details
| Address | 13011 McCallen Pass Austin, Texas 78753 |
| Phone | +1.650.249.9090 |
| Number of Employees | 975 |
| Recent SEC Filing | 09/13/2021 4 |
| President, Chief Executive Officer & Director | Stephen Chapman |
| Chief Operating Officer | Robert A. Schueren |
| Chief Financial Officer | Michael Burkes Brophy |
| Chief Medical Officer & Senior VP-Medical Affairs | Paul R. Billings |
Company Highlights
| Price Open | $112.28 |
| Previous Close | $112.32 |
| 52 Week Range | $65.61 - 129.09 |
| Market Capitalization | $10.8 B |
| Shares Outstanding | 93.8 M |
| Sector | Health Services |
| Industry | Medical/Nursing Services | Next Earnings Announcement | 11/04/2021 |
Options Summary
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
View all fundamentalsFundamentals
| Price / Earnings | N/A |
| Earnings per Share | -$3.66 |
| Beta vs. S&P 500 | N/A |
| Revenue | $257.7 M |
| Net Profit Margin | -62.32% |
| Return on Equity | -74.30% |
Analyst Ratings as of 09/07/2021
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |